David Raben - Chief Medical Officer at Bicara Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Issuer Symbol
BCAX on Nasdaq
All Insider Reports
All Insider Reports

David Raben - trading volume in the past year for Bicara Therapeutics Inc.

Holdings reported by David Raben for Bicara Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 55,286 $209,522 $3.79 26 Dec 2025 Direct
Stock Option (Right to Buy) 100,000 02 Feb 2026 Direct Common Stock

Transactions reported by David Raben for Bicara Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.